Get ready to negotiate, drugmakers: Payers are armed for drug-pricing battle
26 December 2014
If 2014 was the year of the emboldened U.S. payer, then 2015 promises to be the year of the pharma negotiator.
Limited attention span? Focus on these market shake-ups in 2015
25 December 2014
It has been a whirlwind of a year for pharma, with pricing battles, regulatory showdowns and all-but-legendary M&A. And on the ground, it's Rock-em-Sock-em Robots in some of the industry's biggest markets. A steady flow of new drugs in 2014--and a slate of anticipated launches in 2015--have established brands defending their titles and newcomers looking to land a gut-punch or two, if not a knockout. Here are the match-ups to watch in the coming year. Think we missed something? As always, let us know.
Continuous manufacturing reaches a turning point
25 December 2014
For years drug companies have been talking about continuous manufacturing, a drugmaking process that is cheaper, faster, easier on the environment, requires smaller facilities, and can be ramped up quickly in remote locations. Did we mention cheaper?
Will biopharma keep riding that mammoth M&A wave? Short answer's yes
25 December 2014
It's been a wild ride through the M&A world for pharma this year, and analysts predict that may just continue into 2015. Companies have been wheeling and dealing at breakneck pace, with more than a couple inking multiple pacts. But plenty of drugmakers are still in search of a deal that will move the needle.
Russia and neighboring Belarus step up cooperation in R&D
24 December 2014
Next year may see the launch of 17 large-scale Russo-Belarusian projects in applied sciences, Belarusian portal Naviny.by reported, citing Alexander Shumilin, the chairman of Belarus’ State Committee for Science and Technology. According to the government official, these are projects in areas such as biotechnology, medicine, space research, information and telecommunications technologies, new materials, nanotechnology, and laser technology.
J.P. Morgan's 6 Top Biotech and Pharmaceuticals Stocks to Buy in 2015
24 December 2014
Which biotech and pharmaceuticals stocks should investors buy in 2015? J.P. Morgan analysts named six "Pharmaceuticals, Biotechnology" companies with the best investment cases as part of its top U.S. stocks picks for 2015. The overall stock picks list includes 48 companies across sectors and strategy focus. The firm only chose companies with at least $5 million in average daily trading volume.
Best and worst 2014 biotech performers on Wall Street
24 December 2014
A little profit-taking in biotech into year end is only to be expected from Wall Street after such a strong year. Some of the most likely victims for a bit of bloodletting are the strongest winners. Or these companies might be able to keep up their momentum on the back of biotech excitement going into the definitive industry extravaganza, the J.P. Morgan Healthcare conference in mid-January.
India slashes health budget, already one of the world's lowest
24 December 2014
The Indian government has ordered a cut of nearly 20 percent in its 2014/15 healthcare budget due to fiscal strains, putting at risk key disease control initiatives in a country whose public spending on health is already among the lowest in the world.
More New Drugs and Faster Approvals
23 December 2014
FDA set several milestones in approving more new, important drugs and biologics in 2014. Breakthrough drug designations went through through the roof, speeding more new therapies for cancer and critical conditions to patients. FDA approved 35 novel new drugs, up from 27 in 2013, reported FDA commissioner Margaret Hamburg in December 2014.
Year in Review: Key Outsourcing Trends
23 December 2014
According to BioPlan’s 11th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production(1), which identifies various industry trends, almost all areas of R&D and manufacturing are at least in contention for some degree of outsourcing. CMOs are becoming sought-after partners as a result of their use of innovative technologies, single-use bioreactors, and other novel bioprocessing services.
06 September 2024
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
The Russian government will support the development and production of modern drugs
16 September 2024
Russia’s Long-Lasting Flu Vaccine Undergoes Trials
16 September 2024
Moscow to Launch Digitalization Course for Students
12 September 2024
Russia has created an oral drug aimed at treating obesity and diabetes
12 September 2024